Laser microdissection of small tissue samples - Application to chronic pancreatitis tissues

Pathology Research and Practice

Volumn 199, Issue 6, 2003, Pages 363-371

  Heinmöller, Ernst ^a   Bockholt, Anke ^a   Werther, Meike ^a   Ziemer, Maria ^a   Müller, Annegret ^b   Ghadimi, B Michael ^b   Rüschoff, Josef ^a  

^a KLINIKUM KASSEL   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Chronic pancreatitis; Laser microdissection; Loss of heterozygosity; Tumor suppressor genes

Indexed keywords

DNA; PROTEIN P16; PROTEIN P53; RNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CARCINOGENESIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LASER; LASER MICRODISSECTION; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; PANCREAS CANCER; PANCREAS DUCT; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STANDARD; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

EID: 0042063848     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00432     Document Type: Article

References (45)

1. Bardeesy N, DePinho RA (2002) Pancreatic cancer biology and genetics. Nat Rev Cancer 2: 897-909
2. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR (1994) An evaluation of six antibodies for inummohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12
3. Becker I, Becker KF, Röhrl MH, Minkus G, Schütze K and Höfler H (1996) Single-cell mutation analysis of tumors from stained histologic slides. Lab Invest 75: 801-807
4. Beltinger CP, Klimek F and Debatin KM (1997) Whole genome amplification of single cells from clinical peripheral blood smears. J Clin Pathol Mol Pathol 50: 272-275
5. Bernsen MR, Dijkman HB, de Vries E, Figdor CG, Ruiter DJ, Adema GJ, Muijen GN (1998) Identification of mRNA and DNA sequences from small tissue samples isolated by laser-assisted microdissection. Lab Invest 78: 1267-1273
6. Boehm M and Wieland I (1997) Analysis of tumour-specific alterations in native specimens by PCR: How to procure the tumour cells. Int J Oncology 10: 131-139
7. Böhm M, Wieland I, Scütze K, Rubben H (1997) Microbeam MOMeNT: non-contact laser microdissection of membrane-mounted native tissue. Am J Pathol. 151: 63-67
8. Bunz F, Fauth C, Speicher MR, Dutriaux. A, Sedivy JM, Kinzler KW, Vogelstein B, Lengauer C (2002) Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res 62: 1129-1133
9. Cairns P, Polascik TJ, Eby Y, Tokino k, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidranski D (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genetics 11: 210-212
10. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Rüschoff J (1997) Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57: 4749-4756
11. Dietmaier W, Hartmann A, Wallinger S, Heinmöller E, Kerner T, Endl E, Jauch KW, Hofstädter F and Rüschoff J (1999) Multiple mutation analyses in single tumour cells with improved whole genome amplification. Am J Pathol 154: 83-95
12. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta LA (1996) Laser capture microdissection. Science 274: 998-1001
13. Etemad B and Whitcomb DC (2001) Chronic pancreatitis: Diagnosis, classification and new genetic developments. Gastroenterology 120: 682-707
14. Fend F and Raffeld M (2000) Laser capture microdissection in pathology. J Clin Pathol 53: 666-672
15. Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, Yeo CJ, Hruban RH, Goggins M (2002) Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 160: 1573-1581
16. Gansauge S, Schmid RM, Muller J, Adler G, Mattfeldt T, Beger HG (1998) Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Brit J Surg 85: 337-340
17. Gerdes B, Ramaswamy A, Kersting M, Ernst M, Lang S, Schuermann M, Wild A, Bartsch, DK (2001) P16INK4a alterations in chronic pancreatitis - indicator for high-risk lesions for pancreatic cancer. Surgery 129: 490-497
18. Hahn SA, Shamsul Hoque ATM, Moskaluk CA, Da Costa LT, Schutte M, Rozenblum E, Seymour AB, Weinstein CL, Yeo CJ, Hruban RH, Kern SE (1996) Homozygous deletions map at 18q21.1 in pancreatic cancer. Cancer Res 56:490-494
19. Hahn S, Zhong XY, Troeger C, Burgemeister R, Gloning K and Holzgreve W (2000) Current applications of single-cell PCR. Cell Mol Life Sci 57:96-105
20. Heinmöller E, Dietmaier W, Zirngibl H, Heinmöller P, Scaringe W, Jauch KW, Hofstädter F and Rüchoff J (2000) Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol 157: 83-92
21. Heinmöller E, Qiang L, Sun Y, Schlake G, Hill KA, Weiss LM and Sommer SS (2002) Toward efficient analysis of mutations in single cells from ethanol-fixed, paraffin-embedded, and immunohistochemically-stained tissues. Lab Invest 82: 443-453
22. Howes N, Greenhalf W, Neoptolemos J (2000) Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis. Med Clin North Am 84: 719-738
23. Hruban H, Adsay V, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Klöppel G, Longnecker DS, Lüttges J, Offerhaus GJA (2000) Pancreatic intraepithelial neoplasia. A new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25: 579-586
24. Hruban RH, Wilentz RE, Kern SE (2000) Genetic progression in the pancreatic ducts. Am J. Pathol 156: 1821-1825
25. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancerprone chronic inflammatory disease. Cancer Res 60: 3333-3337
26. Hussain SP, Amstad P, Raja K, Ambs S, Nagashima M, Bennett WP, Shields PG, Ham AJ, Swenberg JA, Marrogi AJ, Harris CC (2000) Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancerprone chronic inflammatory disease. Cancer Res 60: 3333-3337
27. Kern S, Hruban R, Hollingsworth MA; Brand R, Adrian TE, Jaffee E, Tempero MA (2001) A white paper: The product of a pancreas cancer think tank. Cancer Res 61: 4923-4932
28. Larson PS, de las Morenas A, Bennett SR, Cupples A, Rosenberg CL (2002) Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in coexisting carcinomas. Am J Pathol 161: 283-290
29. Ling G, Persson A, Berne B, Uhlen M, Lundeberg J, Ponten F (2001) Persistent p53 mutations in single cells from normal human skin: Am J Pathol 159: 1247-1253
30. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, AndrenSandberg A, Domellöf L (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328: 1433-1437
31. Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK Jr, Perrault J, Whitcomb D (1997) Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 89: 442-446
32. Lüttges J, Diederichs A, Menke MAOH, Vogel I, Kremer B, Klöppel G (2000) Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53. Cancer 88: 2495-2504
33. Lüttges J, Galehdari H, Bröcker V, Schwarte-Waldhoff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA (2001) Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158: 1677-1683
34. Martin DB, Nelson PS (2001) From genomics to proteomics: techniques and applications in cancer research. Trends Cell Biol 11: 60-65
35. Mehta CR, Pantel NR (1983) A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 78: 427-434
36. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE (1990) Increased cell division as a cause of human cancer. Cancer Res 50: 7415-7421
37. Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE (1997) Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57: 1731-1734
38. Schlegel J, Bocker T, Zirngibl H, Hofstädter F, Rüschoff J (1995) Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based sreening method. Virchows Arch 426: 223-227
39. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG (1997) Abrogation of the Rb/p 16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 57: 3126-3130
40. Schütze K and Lahr G (1998) Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 16:737-742
41. Sun F, Arnheim N and Waterman MS (1995) Whole genome amplification of single cells: Mathematical analysis of PEP and tagged PCR. Nucleic Acids Res 23: 3034-3040
42. Vogelstein B and Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9: 138-141
43. Walch A, Komminoth P, Hutzler P, Aubele M, Höfler H, Werner M (2000) Microdissection of tissue sections: Application to the molecular genetic characterisation of premalignant lesions. Pathobiology 68: 9-17
44. Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T (2000) Genetic progression and divergence in pancreatic carcinoma. Am J Pathol 156: 2123-2133
45. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W and Arnheim N (1992) Whole genome amplification from a single cell: Implications for genetic analysis. Proc Natl Acad Sci USA 89: 5847-5851